Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
出版年份 2022 全文链接
标题
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
作者
关键词
-
出版物
Science Translational Medicine
Volume 14, Issue 670, Pages -
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2022-11-10
DOI
10.1126/scitranslmed.abo3605
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Magnesium sensing via LFA-1 regulates CD8+ T cell effector function
- (2022) Jonas Lötscher et al. CELL
- Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
- (2022) Nikolaos Zacharakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary analysis from DS8201-A-U105: A phase 1b, two-part, open-label study of trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing urothelial carcinoma (UC).
- (2022) Matt D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
- (2022) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
- (2022) Peng Liao et al. CANCER CELL
- Clinical relevance of tumour-associated macrophages
- (2022) Mikael J. Pittet et al. Nature Reviews Clinical Oncology
- Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors
- (2022) Paulien Kaptein et al. Science Translational Medicine
- A phase I/II study of ANV419, a selective IL-2R-beta-gamma targeted antibody-IL-2 fusion protein, in patients with advanced solid tumors.
- (2022) Heinz Läubli et al. JOURNAL OF CLINICAL ONCOLOGY
- Siglec receptors as new immune checkpoints in cancer
- (2022) Michal A. Stanczak et al. MOLECULAR ASPECTS OF MEDICINE
- NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
- (2022) Nicole Kirchhammer et al. Science Translational Medicine
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
- (2021) Alexander M. Menzies et al. NATURE MEDICINE
- Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2021) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paradigms on Immunotherapy Combinations with Chemotherapy
- (2021) Diego Salas-Benito et al. Cancer Discovery
- High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
- (2021) D.J. McGrail et al. ANNALS OF ONCOLOGY
- Next generation of immune checkpoint inhibitors and beyond
- (2021) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
- (2021) Samantha J. Seitter et al. CLINICAL CANCER RESEARCH
- Natural killer cell engagers in cancer immunotherapy: Next generation of immuno‐oncology treatments
- (2021) Olivier Demaria et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
- (2021) Mark A. Socinski et al. Journal of Thoracic Oncology
- Immune checkpoint inhibitors in melanoma
- (2021) Matteo S Carlino et al. LANCET
- Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
- (2021) Enriqueta Felip et al. LANCET
- Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
- (2021) Arjun V Balar et al. LANCET ONCOLOGY
- Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
- (2021) Yugang Guo et al. NATURE IMMUNOLOGY
- Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
- (2021) Benjamin C. Creelan et al. NATURE MEDICINE
- An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
- (2021) Paula Voabil et al. NATURE MEDICINE
- Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
- (2021) Paul Nathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
- (2021) Brian Belmontes et al. Science Translational Medicine
- Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
- (2021) M Ines Pascoal Ramos et al. eLife
- Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment
- (2021) Alba Nicolas-Boluda et al. eLife
- The landscape of bispecific T cell engager in cancer treatment
- (2021) Shujie Zhou et al. Biomarker Research
- Immune Modulatory Properties of Collagen in Cancer
- (2021) Anne Mette Askehøj Rømer et al. Frontiers in Immunology
- HDAC Inhibition to Prime Immune Checkpoint Inhibitors
- (2021) Edith Borcoman et al. Cancers
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
- (2020) Feng Li et al. Journal for ImmunoTherapy of Cancer
- The Emerging Landscape of Immune Cell Therapies
- (2020) Evan W. Weber et al. CELL
- Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
- (2020) Jing Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
- (2020) Alireza Labani-Motlagh et al. Frontiers in Immunology
- Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front
- (2020) Christian M. Schürch et al. CELL
- Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
- (2020) Valentina Bianchi et al. Frontiers in Immunology
- The tumor microenvironment
- (2020) Nicole M. Anderson et al. CURRENT BIOLOGY
- Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
- (2020) Yingjie Bian et al. NATURE
- Targeted glycan degradation potentiates the anticancer immune response in vivo
- (2020) Melissa A. Gray et al. Nature Chemical Biology
- Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
- (2020) Jianjun Gao et al. NATURE MEDICINE
- Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
- (2020) David H. Peng et al. Nature Communications
- Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression
- (2020) Hilal Bhat et al. Frontiers in Immunology
- TIGIT in cancer immunotherapy
- (2020) Joe-Marc Chauvin et al. Journal for ImmunoTherapy of Cancer
- Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
- (2020) Sri Krishna et al. SCIENCE
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
- (2019) Alexander C. Huang et al. NATURE MEDICINE
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- A Variant of a Killer Cell Immunoglobulin-like Receptor is Associated with Resistance to PD-1 Blockade in Lung Cancer
- (2019) Marcel P Trefny et al. CLINICAL CANCER RESEARCH
- Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- (2019) Jun Ishihara et al. Science Translational Medicine
- Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
- (2019) Kyle B. Lupo et al. Cancers
- Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
- (2019) Heinz Läubli et al. Frontiers in Immunology
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
- (2018) Marco B. Schaaf et al. Cell Death & Disease
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
- (2018) Christian U. Blank et al. NATURE MEDICINE
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now